COVID-19 has changed the landscape of healthcare and has, over the past 2 years, dramatically revitalized investor interest in the sector. With Western and Chinese investors the most knowledgeable that they have ever been in vaccine and pharmaceutical development processes, we have seen growing flows of investment capital into all aspects of healthcare. While blue-chip companies like Pfizer, Johnson and Johnson, and Moderna should be on every investor’s watchlist, the up-and-coming small-cap healthcare companies provide some of the most impressive growth opportunities. Finding the next major market mover means looking at the cutting edge of new treatments, technologies and medical devices!
The GCFF Virtual Conference 2022 - Healthcare Investment Conference (Asia Pacific) will be the premier event to connect HNW, institutional and industrial investors in Asia Pacific to the latest investment opportunities in the healthcare sector.
What companies should participate?
Companies that are in the biotech, medical device, pharmaceutical, and digital health sectors with strong growth potential, should consider presenting at this conference. If you know a company that may be a good fit, please contact us for more information.
Who will be Watching?
In this Asia investor focused event, participating companies will have the benefit of presenting to the qualified investors in Asia who have strong interests in the healthcare sector. These investors will include high-net-worth individuals, institutional investors, private family offices or industrial corporate investor groups. This is an invitation-only event with the focus on regions including mainland China, Hong Kong, Taiwan and Singapore.
This will be the perfect opportunity for companies in the healthcare sector to expand their presence with the growing number of investors in the Asia Pacific region. If you are interested in attending this event as an investor, please contact us for more info.